NXI Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Basel
Business model:B2B
NXI Therapeutics is a Swiss biotech startup developing next-gen immunosuppressive drugs for autoimmune diseases and organ transplantation.
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 3.85M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to NXI Therapeutics
Name | Criteria | |
---|---|---|
![]() |
Athera
63%
|
|
![]() |
AttgeNO
63%
|
|
![]() |
Bionomous
63%
|
|
![]() |
Oui
63%
|
|
![]() |
FinnAdvance
63%
|
|
![]() |
Ossiform
63%
|
|
![]() |
Pharmedigroup
63%
|
|
![]() |
ViveBiotech
63%
|
|
![]() |
CellulaREvolution
63%
|
|
![]() |
ResoTher Pharma
63%
|
|